Association of the idiotype:Antiidiotype antibody ratio with the efficacy of intravenous immunoglobulin treatment for the prevention of recurrent autoimmune-associated congenital heart block

Arthritis and Rheumatism

Volumn 63, Issue 9, 2011, Pages 2783-2789

  Routsias, John G ^a   Kyriakidis, Nikolaos C ^a   Friedman, Deborah M ^b   Llanos, Carolina ^c   Clancy, Robert ^d   Moutsopoulos, Haralampos M ^a   Buyon, Jill ^d   Tzioufas, Athanasios G ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b NEW YORK MEDICAL COLLEGE   (United States)

^c PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^d NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ANTIIDIOTYPIC ANTIBODY; AUTOANTIBODY; DNA ANTIBODY; EPITOPE; IDIOTYPIC ANTIBODY; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; LA ANTIBODY;

ANTIBODY TITER; ARTICLE; AUTOIMMUNE DISEASE; CHEMOPROPHYLAXIS; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONGENITAL HEART BLOCK; CONTROLLED STUDY; CORRELATIONAL STUDY; FEMALE; GESTATIONAL AGE; HUMAN; LUPUS VULGARIS; MEDICAL HISTORY; PREGNANT WOMAN; PRIORITY JOURNAL; RASH;

ANTIBODIES, ANTI-IDIOTYPIC; AUTOIMMUNE DISEASES; FEMALE; HEART BLOCK; HUMANS; IMMUNOGLOBULIN IDIOTYPES; IMMUNOGLOBULINS, INTRAVENOUS; PREGNANCY; PROSPECTIVE STUDIES;

EID: 80052313084     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.30464     Document Type: Article

References (30)

1. Buyon JP, Clancy RM,. Maternal autoantibodies and congenital heart block: mediators, markers, and therapeutic approach. Semin Arthritis Rheum 2003; 33: 140-54. (Pubitemid 38030078)
2. Buyon JP, Clancy RM,. Neonatal lupus. In:, Wallace DJ, Hahn BH, editors. Dubois' lupus erythematosus. 7th ed. Philadelphia: Lippincott Williams & Wilkins; 2006. p. 1058-80.
3. Buyon JP, Clancy RM, Friedman DM,. Autoimmune associated congenital heart block: integration of clinical and research clues in the management of the maternal/foetal dyad at risk. J Intern Med 2009; 265: 653-62.
4. Cimaz R, Spence DL, Hornberger L, Silverman ED,. Incidence and spectrum of neonatal lupus erythematosus: a prospective study of infants born to mothers with anti-Ro autoantibodies. J Pediatr 2003; 142: 678-83. (Pubitemid 36737172)
5. Brucato A, Frassi M, Franceschini F, Cimaz R, Faden D, Pisoni MP, et al. Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis: a prospective study of 100 women. Arthritis Rheum 2001; 44: 1832-5. (Pubitemid 32758230)
6. Buyon JP, Hiebert R, Copel J, Craft J, Friedman D, Katholi M, et al. Autoimmune-associated congenital heart block: demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry. J Am Coll Cardiol 1998; 31: 1658-66. (Pubitemid 28273312)
7. Julkunen H, Eronen M,. The rate of recurrence of isolated congenital heart block: a population-based study. Arthritis Rheum 2001; 44: 487-8.
8. Llanos C, Izmirly PM, Katholi M, Clancy RM, Friedman DM, Kim MY, et al. Recurrence rates of cardiac manifestations associated with neonatal lupus and maternal/fetal risk factors. Arthritis Rheum 2009; 60: 3091-7.
9. Strandberg L, Winqvist O, Sonesson SE, Mohseni S, Salomonsson S, Bremme K, et al. Antibodies to amino acid 200-239 (p200) of Ro52 as serological markers for the risk of developing congenital heart block. Clin Exp Immunol 2008; 154: 30-7.
10. Stea EA, Routsias JG, Clancy RM, Buyon JP, Moutsopoulos HM, Tzioufas AG,. Anti-La/SSB antiidiotypic antibodies in maternal serum: a marker of low risk for neonatal lupus in an offspring. Arthritis Rheum 2006; 54: 2228-34. (Pubitemid 44051079)
11. Friedman DM, Llanos C, Izmirly PM, Brock B, Byron J, Copel J, et al. Evaluation of fetuses in a study of intravenous immunoglobulin as preventive therapy for congenital heart block: results of a multicenter, prospective, open-label clinical trial. Arthritis Rheum 2010; 62: 1138-46.
12. Routsias JG, Touloupi E, Dotsika E, Moulia A, Tsikaris V, Sakarellos C, et al. Unmasking the anti-La/SSB response in sera from patients with Sjögren's syndrome by specific blocking of anti-idiotypic antibodies to La/SSB antigenic determinants. Mol Med 2002; 8: 293-305.
13. Routsias JG, Dotsika E, Touloupi E, Papamattheou M, Sakarellos C, Sakarellos-Daitsiotis M, et al. Idiotype-anti-idiotype circuit in non-autoimmune mice after immunization with the epitope and complementary epitope 289-308aa of La/SSB: implications for the maintenance and perpetuation of the anti-La/SSB response. J Autoimmun 2003; 21: 17-26. (Pubitemid 36871683)
14. Clancy RM, Kapur RP, Molad Y, Askanase AD, Buyon JP,. Immunohistologic evidence supports apoptosis, IgG deposition, and novel macrophage/fibroblast crosstalk in the pathologic cascade leading to congenital heart block. Arthritis Rheum 2004; 50: 173-82. (Pubitemid 38084302)
15. Yu Z, Lennon VA,. Mechanism of intravenous immune globulin therapy in antibody-mediated autoimmune diseases. N Engl J Med 1999; 340: 227-8. (Pubitemid 29063222)
16. Leach JL, Sedmak DD, Osborne JM, Rahill B, Lairmore MD, Anderson CL,. Isolation from human placenta of the IgG transporter, FcRn, and localization to the syncytiotrophoblast: implications for maternal-fetal antibody transport. J Immunol 1996; 157: 3317-22. (Pubitemid 126449142)
17. Miranda-Carus ME, Askanase AD, Clancy RM, Di Donato F, Chou TM, Libera MR, et al. Anti-SSA/Ro and anti-SSB/La autoantibodies bind the surface of apoptotic fetal cardiocytes and promote secretion of TNF-α by macrophages. J Immunol 2000; 165: 5345-51.
18. Pisoni CN, Brucato A, Ruffatti A, Espinosa G, Cervera R, Belmonte-Serrano M, et al. Failure of intravenous immunoglobulin to prevent congenital heart block: findings of a multicenter, prospective, observational study. Arthritis Rheum 2010; 62: 1147-52.
19. Oak S, Gilliam LK, Landin-Olsson M, Torn C, Kockum I, Pennington CR, et al. The lack of anti-idiotypic antibodies, not the presence of the corresponding autoantibodies to glutamate decarboxylase, defines type 1 diabetes. Proc Natl Acad Sci U S A 2008; 105: 5471-6. (Pubitemid 351753887)
20. Baekkeskov S, Aanstoot HJ, Christgau S, Reetz A, Solimena M, Cascalho M, et al. Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 1990; 347: 151-6.
21. Verge CF, Gianani R, Kawasaki E, Yu L, Pietropaolo M, Jackson RA, et al. Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies. Diabetes 1996; 45: 926-33. (Pubitemid 26225509)
22. Djoumerska I, Tchorbanov A, Pashov A, Vassilev T,. The autoreactivity of therapeutic intravenous immunoglobulin (IVIG) preparations depends on the fractionation methods used. Scand J Immunol 2005; 61: 357-63. (Pubitemid 40637841)
23. Dietrich G, Kaveri SV, Kazatchkine MD,. A V region-connected autoreactive subfraction of normal human serum immunoglobulin G. Eur J Immunol 1992; 22: 1701-6.
24. Vassilev TL, Bineva IL, Dietrich G, Kaveri SV, Kazatchkine MD,. Variable region-connected, dimeric fraction of intravenous immunoglobulin enriched in natural autoantibodies. J Autoimmun 1995; 8: 405-13.
25. 2-dependent mechanism the binding of natural IgG autoantibodies from therapeutic immunoglobulin preparations to self-antigens. Eur J Haematol 2005; 74: 101-10. (Pubitemid 40175312)
26. Coutinho A, Kazatchkine MD, Avrameas S,. Natural autoantibodies. Curr Opin Immunol 1995; 7: 812-8. (Pubitemid 26038522)
27. Saenko VA, Kabakov AE, Poverenny AM,. Hidden high-avidity anti-DNA antibodies occur in normal human gammaglobulin preparations. Immunol Lett 1992; 34: 1-5.
28. Bouvet JP, Stahl D, Rose S, Quan CP, Kazatchkine MD, Kaveri SV,. Induction of natural autoantibody activity following treatment of human immunoglobulin with dissociating agents. J Autoimmun 2001; 16: 163-72. (Pubitemid 32552991)
29. Branch DW, Peaceman AM, Druzin M, Silver RK, El-Sayed Y, Silver RM, et al, for the Pregnancy Loss Study Group. A multicenter, placebo-controlled pilot study of intravenous immune globulin treatment of antiphospholipid syndrome during pregnancy. Am J Obstet Gynecol 2000; 182: 122-7. (Pubitemid 30074379)
30. Berkowitz RL, Lesser ML, McFarland JG, Wissert M, Primiani A, Hung C, et al. Antepartum treatment without early cordocentesis for standard-risk alloimmune thrombocytopenia: a randomized controlled trial. Obstet Gynecol 2007; 110: 249-55. (Pubitemid 47356647)